Search

Author/Creator Trim, Paul J.

1. A novel conditional Sgsh knockout mouse model recapitulates phenotypic and neuropathic deficits of Sanfilippo syndrome. Issue 5 (27th April 2017)

Authors:
Lau, Adeline A.; King, Barbara M.; Thorsen, Carly L.; Hassiotis, Sofia; Beard, Helen; Trim, Paul J.; Whyte, Lauren S.; Tamang, Sarah J.; Duplock, Stephen K.; Snel, Marten F.; Hopwood, John J.; Hemsley, Kim M.
Journal:
Journal of inherited metabolic disease
Issue:
Volume 40:Issue 5(2017)
Page Start:
715
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis. Issue 9 (27th December 2017)

Authors:
Xie, Jianling; Shen, Kaikai; Lenchine, Roman V.; Gethings, Lee A.; Trim, Paul J.; Snel, Marten F.; Zhou, Ying; Kenney, Justin W.; Kamei, Makoto; Kochetkova, Marina; Wang, Xuemin; Proud, Christopher G.
Journal:
International journal of cancer
Issue:
Volume 142:Issue 9(2018)
Page Start:
1865
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Evaluation of enzyme dose and dose‐frequency in ameliorating substrate accumulation in MPS IIIA Huntaway dog brain. Issue 2 (25th November 2014)

Authors:
King, Barbara; Marshall, Neil; Beard, Helen; Hassiotis, Sofia; Trim, Paul J.; Snel, Marten F.; Rozaklis, Tina; Jolly, Robert D.; Hopwood, John J.; Hemsley, Kim M.
Journal:
Journal of inherited metabolic disease
Issue:
Volume 38:Issue 2(2015)
Page Start:
341
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Is SGSH heterozygosity a risk factor for early‐onset neurodegenerative disease?. Issue 3 (25th January 2021)

Authors:
Douglass, Meghan L.; Beard, Helen; Shoubridge, Andrew; Nazri, Nazzmer; King, Barbara; Trim, Paul J.; Duplock, Stephen K.; Snel, Marten F.; Hopwood, John J.; Hemsley, Kim M.
Journal:
Journal of inherited metabolic disease
Issue:
Volume 44:Issue 3(2021)
Page Start:
763
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Low‐dose, continuous enzyme replacement therapy ameliorates brain pathology in the neurodegenerative lysosomal disorder mucopolysaccharidosis type IIIA. Issue 3 (24th February 2016)

Authors:
King, Barbara; Hassiotis, Sofia; Rozaklis, Tina; Beard, Helen; Trim, Paul J.; Snel, Marten F.; Hopwood, John J.; Hemsley, Kim M.
Journal:
Journal of neurochemistry
Issue:
Volume 137:Issue 3(2016)
Page Start:
409
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Slow, continuous enzyme replacement via spinal CSF in dogs with the paediatric‐onset neurodegenerative disease, MPS IIIA. Issue 3 (10th November 2016)

Authors:
King, Barbara; Marshall, Neil R.; Hassiotis, Sofia; Trim, Paul J.; Tucker, Justin; Hattersley, Kathryn; Snel, Marten F.; Jolly, Robert D.; Hopwood, John J.; Hemsley, Kim M.
Journal:
Journal of inherited metabolic disease
Issue:
Volume 40:Issue 3(2017)
Page Start:
443
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗